What does Edgewise Therapeutics, Inc. do?

Jun 22 2025 07:04 PM IST
share
Share Via
Edgewise Therapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $41 million and a market cap of $1.52 billion. The company has no dividend yield and negative return on equity.
Overview:
Edgewise Therapeutics, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.

Financial Snapshot:
- Most recent Net Profit: -41 Million (Quarterly Results - Mar 2025)
- Market cap: USD 1,524.35 Million (Micro Cap)

Key Metrics:
- P/E: NA (Loss Making)
- Industry P/E: NA
- Dividend Yield: 0.00%
- Debt Equity: -1.01
- Return on Equity: -34.00%
- Price to Book: 3.55

Contact Details:
No Company Details Available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News